We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Juno Therapeutics Reports New Death in Trial After FDA Lifts Hold
Juno Therapeutics Reports New Death in Trial After FDA Lifts Hold
The fallout continues from a series of deaths in Juno Therapeutics’ leukemia trial, as the company disclosed that it experienced four patient deaths, not three as it had previously reported.